Related Experiment Video
Updated: Sep 28, 2025

06:01
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
15.0K
Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives
Simon F De Meyer1, Friederike Langhauser2, Steffen Haupeltshofer2
1Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Belgium (S.F.D.M.).
Stroke
|April 1, 2022
Summary
Ischemic stroke involves complex thromboinflammation. This review covers new mediators, platelet modulation, immune system roles, and current clinical trials for stroke treatment.
Area of Science:
- Neuroscience
- Immunology
- Cardiovascular Research
Background:
- Ischemic stroke is a major global health issue causing death and disability.
- Thromboinflammation, the interplay of thrombosis and inflammation, drives stroke pathology, leading to vessel occlusion and neuronal damage.
Purpose of the Study:
- To provide an updated overview of thromboinflammation in ischemic stroke.
- To highlight recent discoveries in platelet modulation and immune system regulation within thromboinflammation.
- To review current therapeutic strategies for stroke undergoing clinical trials.
Main Methods:
- Literature review focusing on recent preclinical and clinical studies.
- Analysis of thromboinflammatory mediators and their role in stroke.
- Compilation of data on ongoing clinical trials for stroke therapies.
Main Results:
- Platelet modulation is a key area of recent discovery in stroke research.
- The innate and adaptive immune systems play significant roles in stroke-related thromboinflammation.
- Several novel therapeutic approaches targeting thromboinflammation are in clinical trials.
Conclusions:
- Understanding thromboinflammation is crucial for developing effective ischemic stroke treatments.
- Targeting platelet function and immune responses offers promising therapeutic avenues.
- Ongoing clinical trials are exploring innovative treatments for stroke patients.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
40
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
40
Ischemic Heart Disease: Overview
1.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
957
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
957

